Search the Web for the terms “Zoloft” and “pregnancy,” and the first thing you’ll see is advertising for plaintiffs lawyers touting claims that Zoloft, the blockbuster antidepressant made by Pfizer Inc., causes a gruesome array of birth defects when taken during pregnancy.
So far, however, plaintiffs in ongoing multidistrict litigation against Pfizer have failed to convince a federal judge that there’s a valid causal connection between Zoloft use and birth defects. And now Pfizer and its lawyers at Quinn Emanuel Urquhart & Sullivan, led by mass torts maven Sheila Birnbaum, say the case has gone on long enough.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
